Ryszard Kole
About
In The Last Decade
Ryszard Kole
106 papers receiving 8.0k citations
Hit Papers
Peers
Comparison fields: 5 of 122
- Molecular Biology 7.5k
- Genetics 1.3k
- Genetics 916
- Cardiology and Cardiovascular Medicine 510
- Cancer Research 456
Countries citing papers authored by Ryszard Kole
This map shows the geographic impact of Ryszard Kole's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ryszard Kole with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ryszard Kole more than expected).
Fields of papers citing papers by Ryszard Kole
This network shows the impact of papers produced by Ryszard Kole. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ryszard Kole. The network helps show where Ryszard Kole may publish in the future.
Co-authorship network of co-authors of Ryszard Kole
This figure shows the co-authorship network connecting the top 25 collaborators of Ryszard Kole. A scholar is included among the top collaborators of Ryszard Kole based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ryszard Kole. Ryszard Kole is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Title | Journal | Authors | Indexed citations |
|---|---|---|---|---|
| 1 | Enhanced delivery of peptide-morpholino oligonucleotides with a small molecule to correct splicing defects in the lung | Nucleic Acids Research | Yan L. Dang, Catharina van Heusden et al. | 14 |
| 2 | Engineered U7 Small Nuclear RNA Restores Correct β-Globin Pre-mRNA Splicing in Mouse β IVS2-654 -Thalassemic Erythroid Progenitor Cells | Human Gene Therapy | Natee Jearawiriyapaisarn, Ryszard Kole et al. | 6 |
| 3 | RNA therapeutics: beyond RNA interference and antisense oligonucleotides breakdown → | Nature Reviews Drug Discovery | Ryszard Kole, Adrian R. Krainer et al. | 916 |
| 4 | Targeted Exon Skipping to Address “Leaky” Mutations in the Dystrophin Gene | Molecular Therapy — Nucleic Acids | Sue Fletcher, C. Adkin et al. | 17 |
| 5 | Modulation of RNA splicing as a potential treatment for cancer | PubMed | John A. Bauman, Ryszard Kole | 25 |
| 6 | Mismatched single stranded antisense oligonucleotides can induce efficient dystrophin splice switching | BMC Medical Genetics | A.M. Adams, R. Johnsen et al. | 10 |
| 7 | Exon skipping and dystrophin restoration in patients with Duchenne muscular dystrophy after systemic phosphorodiamidate morpholino oligomer treatment: an open-label, phase 2, dose-escalation study breakdown → | The Lancet | Sebahattin Çirak, Virginia Arechavala‐Gomeza et al. | 656 |
| 8 | Size-Uniform 200 nm Particles: Fabrication and Application to Magnetofection | Journal of Biomedical Nanotechnology | Lamar O. Mair, Ryszard Kole et al. | 13 |
| 9 | Therapeutic Potential of Splice-Switching Oligonucleotides | Oligonucleotides | John A. Bauman, Natee Jearawiriyapaisarn et al. | 122 |
| 10 | Switching on transgene expression by correcting aberrant splicing using multi‐targeting steric‐blocking oligonucleotides | The Journal of Gene Medicine | Ryszard Kole, Bernard Lebleu et al. | 20 |
| 11 | Modification of Alternative Splicing by Antisense Therapeutics | Oligonucleotides | Ryszard Kole et al. | 39 |
| 12 | Therapeutic potential of antisense oligonucleotides as modulators of alternative splicing | Journal of Clinical Investigation | Peter Sazani, Ryszard Kole | 168 |
| 13 | Therapeutic potential of antisense oligonucleotides as modulators of alternative splicing | Journal of Clinical Investigation | Peter Sazani, Ryszard Kole | 165 |
| 14 | Antisense Oligonucleotides as Modulators of Pre-mRNA Splicing | Humana Press eBooks | Halina Sierakowska, Sudhir Agrawal et al. | 9 |
| 15 | Control of alternative splicing by antisense oligonucleotides as a potential chemotherapy: effects on gene expression | Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease | Danielle R. Mercatante, Ryszard Kole | 37 |
| 16 | Restoration of Human β-Globin Gene Expression in Murine and Human IVS2–654 Thalassemic Erythroid Cells by Free Uptake of Antisense Oligonucleotides | Molecular Pharmacology | Thipparat Suwanmanee, Halina Sierakowska et al. | 54 |
| 17 | Restoration of Correct Splicing of Thalassemic β-Globin Pre-mRNA by Modified U1 snRNAs | Journal of Biological Chemistry | Danielle R. Mercatante, Ryszard Kole et al. | 30 |
| 18 | Modification of alternative splicing pathways as a potential approach to chemotherapy | Pharmacology & Therapeutics | Danielle R. Mercatante, Ryszard Kole | 59 |
| 19 | Correction of Aberrant Splicing of the Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) Gene by Antisense Oligonucleotides | Journal of Biological Chemistry | Kenneth J. Friedman, Jolanta Kole et al. | 116 |
| 20 | Aspects of RNase P Structure and Function | Cold Spring Harbor Monograph Archive | Sidney Altman, Emma Jean Bowman et al. | 7 |
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.